TY - JOUR
T1 - Correction to
T2 - Charges of COVID-19 Diagnostic Testing and Antibody Testing Across Facility Types and States (Journal of General Internal Medicine, (2023), 38, 16, (3640-3643), 10.1007/s11606-020-06198-y)
AU - Meiselbach, Mark K.
AU - Bai, Ge
AU - Anderson, Gerard F.
N1 - Publisher Copyright:
© 2021, Society of General Internal Medicine.
PY - 2023/12
Y1 - 2023/12
N2 - In this study, Figure 2a was presented with some coloring inconsistencies with Figure 2b; please see a revised figure here. (Figure presented.) Average charges for COVID-19 testing, by state. a Diagnostic testing (CPT code: 87635), N = 182,149. States that had ten or fewer claims were classified as “No data.” The Medicare reimbursement rate is $51.31. b Antibody testing (CPT code: 86769), N = 318,546. States that had ten or fewer services were classified as “No data.” The Medicare reimbursement rate is $42.13.
AB - In this study, Figure 2a was presented with some coloring inconsistencies with Figure 2b; please see a revised figure here. (Figure presented.) Average charges for COVID-19 testing, by state. a Diagnostic testing (CPT code: 87635), N = 182,149. States that had ten or fewer claims were classified as “No data.” The Medicare reimbursement rate is $51.31. b Antibody testing (CPT code: 86769), N = 318,546. States that had ten or fewer services were classified as “No data.” The Medicare reimbursement rate is $42.13.
UR - http://www.scopus.com/inward/record.url?scp=85118327363&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118327363&partnerID=8YFLogxK
U2 - 10.1007/s11606-021-07201-w
DO - 10.1007/s11606-021-07201-w
M3 - Comment/debate
C2 - 34725777
AN - SCOPUS:85118327363
SN - 0884-8734
VL - 38
SP - 3660
JO - Journal of general internal medicine
JF - Journal of general internal medicine
IS - 16
ER -